Neil Woodford Opens New Equity Income Fund

Super-popular fund manager Neil Woodford has opened his new equity income fund, and some fear its arrival could disrupt the market for even sizable FTSE 100 companies, such as AstraZeneca (LSE: AZN) and BAE Systems (LSE: BA). Can Woodford get up-and-running without the prices of his favourite firms going haywire?

Astra's rival GlaxoSmithKline is one of five shares in the FTSE 100 that our top analysts have highlighted in our special report "5 Shares To Retire On". To find out the reasons behind their inclusion, and the names of the other four shares, simply click here to have it delivered completely free to your inbox.

The Motley Fool has recommended shares in GlaxoSmithKline.